204 related articles for article (PubMed ID: 31365979)
1. [Evaluation of quality of life in patients with Graves orbitopathy and its influencing factors].
Weng CY; Li ZF; Hu SD; Luo YS; Feng XT; Zhong Q; Zhang Q; Shen J
Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):577-583. PubMed ID: 31365979
[No Abstract] [Full Text] [Related]
2. Quality of life in a german graves orbitopathy population.
Ponto KA; Hommel G; Pitz S; Elflein H; Pfeiffer N; Kahaly GJ
Am J Ophthalmol; 2011 Sep; 152(3):483-490.e1. PubMed ID: 21676374
[TBL] [Abstract][Full Text] [Related]
3. Measurement Properties of the Persian Translated Version of Graves Orbitopathy Quality of Life Questionnaire: A Validation Study.
Kashkouli MB; Karimi N; Aghamirsalim M; Abtahi MB; Nojomi M; Shahrad-Bejestani H; Salehi M
Ophthalmic Epidemiol; 2017 Feb; 24(1):3-10. PubMed ID: 28001456
[TBL] [Abstract][Full Text] [Related]
4. Assessing quality of life in Taiwanese patients with Graves' ophthalmopathy.
Lin IC; Lee CC; Liao SL
J Formos Med Assoc; 2015 Nov; 114(11):1047-54. PubMed ID: 24434244
[TBL] [Abstract][Full Text] [Related]
5. Related quality of life questionnaire specific to dysthyroid ophthalmopathy evaluated in a population of patients with Graves' disease.
Delfino LC; Zunino A; Sapia V; Croome MDCS; Ilera V; Gauna AT
Arch Endocrinol Metab; 2017; 61(4):374-381. PubMed ID: 28225858
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of disease-specific quality of life and its influencing factors in Bulgarian patients with Graves' orbitopathy.
Stoynova MA; Shinkov AD; Dimitrova ID; Yankova IA; Kovatcheva RD
Int Ophthalmol; 2024 Feb; 44(1):68. PubMed ID: 38347322
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Graves' Orbitopathy-Specific Quality of Life Questionnaire in the Mainland Chinese Population.
Zeng P; Fan SX; Li ZJ; Peng YY; Hu YX; Xu MT; Wang M
J Ophthalmol; 2019; 2019():7602419. PubMed ID: 31011452
[TBL] [Abstract][Full Text] [Related]
8. Assessing Graves' ophthalmopathy-specific quality of life in Korean patients.
Choi YJ; Lim HT; Lee SJ; Lee SY; Yoon JS
Eye (Lond); 2012 Apr; 26(4):544-51. PubMed ID: 22241019
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients.
Villagelin D; Romaldini J; Andrade J; Santos R; Milkos A; Teixeira PFDS; Ward LS
Front Endocrinol (Lausanne); 2019; 10():192. PubMed ID: 31024443
[No Abstract] [Full Text] [Related]
10. Which factors are associated with quality of life in patients with Graves' orbitopathy presenting for orbital decompression surgery?
Wickwar S; McBain HB; Ezra DG; Hirani SP; Rose GE; Newman SP
Eye (Lond); 2015 Jul; 29(7):951-7. PubMed ID: 25998940
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Ophthalmic Surgery for Graves' Orbitopathy on Quality of Life: A Systematic Review and Meta-Analysis.
Woo T; Li C; Ganesananthan S; Rajendram R; Uddin J; Lee RWJ; Dayan C; Taylor P
Thyroid; 2022 Feb; 32(2):177-187. PubMed ID: 34877883
[No Abstract] [Full Text] [Related]
12. Assessing the quality of life in Indian Graves' orbitopathy patients and validation of Hindi version of GO-QOL questionnaire.
Delampady K; Reddy SVB; Yadav SB
Indian J Ophthalmol; 2020 Aug; 68(8):1617-1621. PubMed ID: 32709791
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of thyroid eye disease: quality-of-life questionnaire (TED-QOL) in Korean patients.
Son BJ; Lee SY; Yoon JS
Can J Ophthalmol; 2014 Apr; 49(2):167-73. PubMed ID: 24767223
[TBL] [Abstract][Full Text] [Related]
14. GO-QOL--disease-specific quality of life questionnaire in Graves' orbitopathy.
Sawicka-Gutaj N; Bednarczuk T; Daroszewski J; Waligórska-Stachura J; Miśkiewicz P; Sowiński J; Bolanowski M; Ruchała M
Endokrynol Pol; 2015; 66(4):362-6. PubMed ID: 26323474
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of quality of life in patients with Graves´ ophthalmopathy, before and after orbital decompression.
Iacobæus L; Sahlin S
Orbit; 2016 Jun; 35(3):121-5. PubMed ID: 27159575
[TBL] [Abstract][Full Text] [Related]
16. Quality of life improves after strabismus surgery in patients with Graves' orbitopathy.
Jellema HM; Merckel-Timmer E; Kloos R; Saeed P; Mourits MP
Eur J Endocrinol; 2014 May; 170(5):785-9. PubMed ID: 24493116
[TBL] [Abstract][Full Text] [Related]
17. Objective and subjective outcomes of strabismus surgery in Graves' orbitopathy: a prospective multicentre study.
Jellema HM; Saeed P; Mombaerts I; Dolman PJ; Garrity J; Kazim M; Dhrami-Gavazi E; Lyons C; Nieuwkerk P; Mourits MP
Acta Ophthalmol; 2017 Jun; 95(4):386-391. PubMed ID: 28133945
[TBL] [Abstract][Full Text] [Related]
18. Establishing the usefulness of the GO-QOL in a UK hospital-treated population with thyroid eye disease in the CIRTED trial.
Dietrich A; Taylor P; White P; Wilson V; Uddin J; Lee RWJ; Dayan C; Jackson S;
Psychol Health Med; 2018; 23(sup1):1341-1355. PubMed ID: 30092670
[TBL] [Abstract][Full Text] [Related]
19. Facial expression of patients with Graves' orbitopathy.
Lei C; Qu M; Sun H; Huang J; Huang J; Song X; Zhai G; Zhou H
J Endocrinol Invest; 2023 Oct; 46(10):2055-2066. PubMed ID: 37005981
[TBL] [Abstract][Full Text] [Related]
20. Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions.
Campi I; Currò N; Vannucchi G; Covelli D; Simonetta S; Fugazzola L; Dazzi D; Pignataro L; Guastella C; Lazzaroni E; Pirola G; Salvi M
Thyroid; 2021 Feb; 31(2):280-287. PubMed ID: 32940167
[No Abstract] [Full Text] [Related]
[Next] [New Search]
